BRV Capital Management: Funding, Team & Investors | Startup Intros

Loading organizations...

BRV Capital Management: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 22, 2026	GIGR	$5.4M Pre-Seed	BRV Capital Management, Mirae Asset Venture Investment	Bora Chung, Jihoon Yoo, Jihun Yu, Krew Capital
Jun 1, 2025	Spekter Games	$5.0M Seed	—	Alumni Ventures, Costanoa Ventures, Matchstick Ventures, Sapphire Ventures, Robin Guo, Accelerator Ventures, Alumni Ventures, Chamaeleon, Impact46, London Venture Partners, Versus Ventures
Jun 14, 2023	Fitpet	$22.0M Other Equity	—	Industrial Bank of Korea, LB Investment, Shinhan Capital
Mar 30, 2023	Green Labs	$38.5M Debt	BRV Capital Management, SkyLake Equity Partners	—
Mar 21, 2023	OP3N	$28.0M Series A	Animoca Brands	Russell Westbrook, Blizzard Fund, Creative Artists Agency, Dragonfly Capital, Galaxy Digital, GSR, New Enterprise Associates, Republic, Spartan Group, Superscrypt, Warner Music Group
Feb 1, 2023	Verismo Therapeutics	$7.0M Seed	Kwan Yoon	Activant Capital, BlueRun Ventures, Future Shape, Mundi Ventures, UK
Sep 1, 2022	Swiftly	$100.0M Series C	BRV Capital Management	BlueRun Ventures
May 9, 2022	OHouse	$182.0M Series D	—	BOND, IMM Investment, Korea Development Bank, Mirae Asset Capital, JP (Joonpyo) Lee, Temasek, Vertex Growth
May 8, 2022	Bucketplace	$182.0M Series D	—	Bond Capital, IMM Investment, Korea Development Bank, Mirae Asset Capital, SoftBank Ventures Asia, Vertex Growth
Feb 22, 2022	Typecast (aka Neosapience)	$21.5M Series B	Yeemin Chung, Quantum Ventures, STIC Ventures	Company K Partners, Daekyo Investment, TimeWorks Investment
Jan 25, 2022	Greenlabs	$140.0M Series C	—	SK Square, SkyLake Equity Partners
Jan 20, 2022	Green Labs	$140.0M Series C	BRV Capital Management	SK Square, SkyLake Equity Partners
Feb 1, 2021	Jackpocket	$50.0M Series C	—	Raine Ventures, Spero Ventures, Richard Rosenblatt, David Blitzer, Jon Ledecky, Sean Hayes, Circle K Ventures, Gaingels, Greenspring Associates, Gordon Rubenstein, TEGNA
May 1, 2020	Arvelle Therapeutics	$43.0M Series A	—	Andera Partners, F-Prime Capital, H.I.G. BioHealth Partners, KB Investment, LSP, Matt Bullard
Feb 1, 2019	Arvelle Therapeutics	$180.0M Series A	—	Andera Partners, H.I.G. BioHealth Partners, martijn kleijwegt, NovaQuest Capital Management